U.S. market Closed. Opens in 1 day 5 hours 29 minutes

KDNY | Chinook Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue6.13M51.62M827.00K17.26M15.09M17.24M50.68M72.98M
Cost of Revenue1.72M1.69M422.00K554.00K584.00K559.00K549.00K89.00K
Gross Profit4.41M49.94M405.00K16.70M14.50M16.68M50.13M72.89M
Operating Expenses179.22M130.57M55.54M19.97M115.86M123.13M122.00M86.45M
Selling, General & Admin36.29M31.90M19.07M2.96M36.03M33.75M34.28M27.80M
Research & Development141.21M96.99M36.05M17.01M75.84M89.38M87.72M58.65M
Other Operating Expenses1.72M1.69M422.00K299.00K3.99MN/AN/AN/A
Operating Income-185.08M-99.04M-56.23M-19.97M-101.36M-106.45M-71.86M-13.56M
Other Expenses / Income4.81M-170.00K-27.40M-64.82M5.22M3.23M2.18M-25.74M
Before Tax Income-180.27M-99.21M-83.62M-46.52M-96.14M-103.23M-69.68M-39.31M
Income Tax Expenses4.34M2.09M-2.00M332.00K783.00K11.36M-21.46M-99.00K
Net Income-184.62M-101.30M-81.62M-46.85M-95.36M-91.86M-91.15M-39.21M
Interest Expenses7.18MN/A15.00K33.00KN/AN/A2.22M494.00K
Basic Shares Outstanding64.37M45.61M13.17M42.16M78.81B72.90B65.20B44.71B
Diluted Shares Outstanding64.37M45.61M13.17M42.16M78.81B72.90B65.20B44.71B
EBITDA-164.20M-57.17M-53.98M-19.45M-101.36M-106.45M-71.86M-13.56M
EBITDA Margin-2,679.44%-110.74%-6,527.45%-112.68%-671.84%-617.51%-141.79%-18.59%
EBIT-173.10M-99.21M-83.61M-46.49M-94.57M-80.50M-110.39M-38.81M
EBIT Margin-2,824.67%-192.17%-10,110.04%-269.36%-626.86%-466.96%-217.82%-53.19%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙